Your browser doesn't support javascript.
loading
Endoplasmic reticulum chaperones stabilize ligand-receptive MR1 molecules for efficient presentation of metabolite antigens.
McWilliam, Hamish E G; Mak, Jeffrey Y W; Awad, Wael; Zorkau, Matthew; Cruz-Gomez, Sebastian; Lim, Hui Jing; Yan, Yuting; Wormald, Sam; Dagley, Laura F; Eckle, Sidonia B G; Corbett, Alexandra J; Liu, Haiyin; Li, Shihan; Reddiex, Scott J J; Mintern, Justine D; Liu, Ligong; McCluskey, James; Rossjohn, Jamie; Fairlie, David P; Villadangos, Jose A.
Affiliation
  • McWilliam HEG; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia; hamish.mcwilliam@unimelb.edu.au d.fairlie@imb.uq.edu.au j.villadangos@unimelb.edu.au.
  • Mak JYW; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, VIC 3010, Australia.
  • Awad W; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
  • Zorkau M; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, The University of Queensland, Brisbane, QLD 4072, Australia.
  • Cruz-Gomez S; Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
  • Lim HJ; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, VIC 3800, Australia.
  • Yan Y; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
  • Wormald S; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
  • Dagley LF; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
  • Eckle SBG; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
  • Corbett AJ; Division of Systems Biology and Personalised Medicine, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
  • Liu H; Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia.
  • Li S; Division of Systems Biology and Personalised Medicine, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
  • Reddiex SJJ; Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia.
  • Mintern JD; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
  • Liu L; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
  • McCluskey J; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, VIC 3010, Australia.
  • Rossjohn J; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
  • Fairlie DP; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Parkville, VIC 3010, Australia.
  • Villadangos JA; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Proc Natl Acad Sci U S A ; 117(40): 24974-24985, 2020 10 06.
Article in En | MEDLINE | ID: mdl-32958637
ABSTRACT
The antigen-presenting molecule MR1 (MHC class I-related protein 1) presents metabolite antigens derived from microbial vitamin B2 synthesis to activate mucosal-associated invariant T (MAIT) cells. Key aspects of this evolutionarily conserved pathway remain uncharacterized, including where MR1 acquires ligands and what accessory proteins assist ligand binding. We answer these questions by using a fluorophore-labeled stable MR1 antigen analog, a conformation-specific MR1 mAb, proteomic analysis, and a genome-wide CRISPR/Cas9 library screen. We show that the endoplasmic reticulum (ER) contains a pool of two unliganded MR1 conformers stabilized via interactions with chaperones tapasin and tapasin-related protein. This pool is the primary source of MR1 molecules for the presentation of exogenous metabolite antigens to MAIT cells. Deletion of these chaperones reduces the ER-resident MR1 pool and hampers antigen presentation and MAIT cell activation. The MR1 antigen-presentation pathway thus co-opts ER chaperones to fulfill its unique ability to present exogenous metabolite antigens captured within the ER.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Histocompatibility Antigens Class I / Minor Histocompatibility Antigens / Proteomics / Endoplasmic Reticulum / Metabolome Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Histocompatibility Antigens Class I / Minor Histocompatibility Antigens / Proteomics / Endoplasmic Reticulum / Metabolome Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2020 Type: Article